Year-two Follow-up Results of an Observational Study Conducted in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis Patients Treated with Infliximab Biosimilar CT-P13 in a Real-life Setting

被引：0
|
作者：
Fautrel, Bruno [1 ,2 ]
Assing, Maryse [3 ]
Mammar, Nadir [3 ]
Brault, Yves [3 ]
Marotte, Hubert [4 ]
机构：
[1] Sorbonne Univ, Paris, France
[2] Pierre Louis Inst Epidemiol & Publ Hlth, Paris, France
[3] Pfizer, Paris, France
[4] INSERM 1059, St Etienne, France
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1426
引用
收藏
页码：2810 / 2812
页数：3
相关论文
共 50 条
  • [31] Real-life drug persistence in patients with rheumatic diseases treated with CT-P13: a prospective observational cohort study (PERSIST)
    Taylor, Peter C.
    Christensen, Robin
    Moosavi, Shahrzad
    Selema, Pamela
    Guilatco, Ruffy
    Fowler, Heather
    Mueller, Markus
    Liau, Katherine F.
    Haraoui, Boulos
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2021, 5 (02)
  • [32] DRUG SURVIVAL AND IMMUNOGENICITY AFTER SWITCHING FROM REMICADE® TO BIOSIMILAR CT-P13 IN INFLAMMATORY BOWEL DISEASE PATIENTS: TWO YEAR FOLLOW-UP OF A PROSPECTIVE OBSERVATIONAL COHORT STUDY
    Smits, Lisa
    Derikx, Lauranne
    van Esch, Aura
    Drenth, Joost
    Boshuizen, Ronald
    De Jong, Dirk J.
    Hoentjen, Frank
    GASTROENTEROLOGY, 2018, 154 (06) : S822 - S822
  • [33] REAL-WORLD SAFETY DATA FROM PATIENTS WITH RHEUMATIC DISEASES TREATED WITH CT-P13, AN INFLIXIMAB BIOSIMILAR: AN INTERIM ANALYSIS FROM AN OBSERVATIONAL STUDY
    Taylor, Peter C.
    Christensen, Robin
    Moosavi, Shahrzad
    Selema, Pamela
    Guilatco, Ruffy
    Fowler, Heather
    Bombardier, Claire
    Haraoui, Boulos
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 729 - 729
  • [34] TREAT TO TARGET MULTIAPPROACH MODEL IN A 3 YEAR FOLLOW-UP COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS. REAL-LIFE EFFECTIVENESS
    Santos-Moreno, Pedro
    Villarreal-Peralta, Laura
    Cabrera, Michael
    Buitrago-Garcia, Diana
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S56 - S56
  • [35] Effectiveness and safety of golimumab in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under real-life clinical conditions: non-interventional GO-NICE study in Germany
    Krueger, Klaus
    Burmester, Gerd R.
    Wassenberg, Siegfried
    Bohl-Buehler, Martin
    Thomas, Matthias H.
    BMJ OPEN, 2018, 8 (06):
  • [36] Drug survival and immunogenicity after switching from Remicade® to biosimilar CT-P13 in inflammatory bowel disease patients: Two-year follow-up of a prospective observational cohort study
    Smits, L.
    Derikx, L.
    van Esch, A.
    Drenth, J.
    Boshuizen, R.
    de Jong, D.
    Hoentjen, F.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S353 - S353
  • [37] Drug Survival and Immunogenicity After Switching From Remicade to Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: Two-year Follow-up of a Prospective Observational Cohort Study
    Smits, Lisa J. T.
    van Esch, Aura A. J.
    Derikx, Lauranne A. A. P.
    Boshuizen, Ronald
    de Jong, Dirk J.
    Drenth, Joost P. H.
    Hoentjen, Frank
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (01) : 172 - 179
  • [38] Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers
    Tursi, Antonio
    Mocci, Giammarco
    Faggiani, Roberto
    Allegretta, Leonardo
    Della Valle, Nicola
    Forti, Giacomo
    Franceschi, Marilisa
    Ferronato, Antonio
    Gallina, Sara
    Larussa, Tiziana
    Luzza, Francesco
    Lorenzetti, Roberto
    Penna, Antonio
    Rodino, Stefano
    Sebkova, Ladislava
    Lauria, Angelo
    Piergallini, Simona
    Pranzo, Giuseppe
    Ricciardelli, Cristina
    Zampaletta, Costantino
    Elisei, Walter
    Picchio, Marcello
    ANNALS OF GASTROENTEROLOGY, 2019, 32 (04): : 392 - 399
  • [39] The comparative one-year performance of anti-tumor necrosis factor α drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis:: Results from a longitudinal, observational, multicenter study
    Heiberg, Marte Schrumpf
    Koldingsnes, Wenche
    Mikkelsen, Knut
    Rodevand, Erik
    Kaufmann, Cecilie
    Mowinckel, Petter
    Kvien, Tore K.
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (02): : 234 - 240
  • [40] Real-life experience of tofacitinib in patients with treatment-resistant rheumatoid arthritis: A 5-year follow-up: Monocentric experience
    Pehlivan, Ozlem
    NORTHERN CLINICS OF ISTANBUL, 2022, 9 (04) : 376 - 384
12345